Eugène McFadden

Clinical End Points in Coronary Stent Trials

Donald E. Cutlip, Stephan Windecker, Roxana Mehran et al. · Circulation · 2007 · 5.4K citations

Medicine, Cardiology, Health Technology Assessment +13

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

Marco Valgimigli, Héctor Bueno, Robert A. Byrne et al. · European Heart Journal · 2017 · 3K citations · Full text

Medicine, Cardiology, Pharmacotherapy +14

Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy

Eugène McFadden, Eugenio Stabile, Evelyn Regar et al. · The Lancet · 2004 · 1.4K citations

Medicine, Cardiology, Pharmacology +16

High-Resolution Spiral Computed Tomography Coronary Angiography in Patients Referred for Diagnostic Conventional Coronary Angiography

Nico R. Mollet, Filippo Cademartiri, Carlos A.G. van Mieghem et al. · Circulation · 2005 · 1K citations

Medicine, Internal Medicine, Radiology +15

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 785 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16